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Objective: To synthesize results from pertinent studies and determine if fasting and/or non‑fasting 
triglycerides are a risk factor for ischemic stroke. Method: We performed two independent 
systematic literature searches using the PubMed and ScienceDirect databases to identify studies 
examining the relationship between fasting and non‑fasting triglyceride concentrations and 
ischemic stroke risk. A meta‑analysis was performed using ischemic stroke as a primary endpoint. 
Results: Twenty‑five reports were identified, including 13 prospective cohort and 12 case–
control studies. Baseline characteristics, study samples, methods, and primary outcomes 
varied. Of 13 prospective cohort studies, nine assessed triglyceride concentrations in the 
fasting state. Seven of these identified triglycerides as an independent risk factor for ischemic 
stroke risk (n = 1624 ischemic cases). Three prospective cohort studies identified a positive 
association between elevated non‑fasting triglyceride concentrations and ischemic stroke risk 
(n = 2050 ischemic cases). One prospective cohort study that compared fasting and non‑fasting 
triglycerides identified only non‑fasting triglycerides as an independent risk factor for ischemic 
stroke. Of 12 case–control studies identified, five identified a positive relationship between 
ischemic stroke risk and elevated fasting triglycerides (n = 838 cases). Seven case–control 
studies were included in the meta‑analysis (n = 1996 ischemic stroke cases), revealing an 
odds ratio of 1.15 (95% CI, 1.08–1.21). Conclusions: The available data are inconsistent. 
The relationship between triglyceride levels and ischemic stroke needs further investigation 
under standardized conditions. We recommend a standardized triglyceride tolerance test to 
further investigate the associations between fasting versus non‑fasting triglyceride levels 
and ischemic stroke.
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status (Austin, 1991; Sarwar et al., 2006; Ridker, 2008). Rhoads and 
Feinleib (1983), for instance, found that Puerto Rican and Japanese 
men had higher median triglyceride values than men of Caucasian 
descent. As larger samples of stroke patients of different ethnici-
ties are being studied however (Sarwar et al., 2006), it is becoming 
increasingly apparent that methodological differences across stud-
ies might be playing a larger role (Bansal et al., 2007).
Traditionally measured in the fasting state to avoid variability 
(Ridker, 2008), mounting evidence supports the assessment of 
non-fasting triglyceride concentrations to determine stroke risk 
(Zilversmit, 1979; Ryu et al., 1992; Bengtsson et al., 1993; Stensvold 
et al., 1993; Jeppesen et al., 1998; Abdel-Maksoud and Hokanson, 
2002). Because no consistent set of prospective cohort data spe-
cifically comparing fasting versus non-fasting triglycerides as a 
measure of stroke risk exist, it remains unclear which state is more 
efficacious.
It is also possible that risk could vary across genders, as one meta-
analysis found that plasma triglyceride levels in women associated 
twice as strongly with cardiovascular disease risk than those in men 
(Hokanson and Austin, 1996).
IntroductIon
Though it is well established that the number and severity of vascu-
lar risk factors contribute to stroke risk (Blumenfeld, 2002; Towfighi 
and Ovbiagele, 2008), it is clear that the list of known risk factors 
to date is not complete. Triglycerides are circulating lipid compo-
nents that are among the many long-speculated modifiable risk 
factors for ischemic stroke (Albrink and Man, 1959; Zimmermann 
et al., 2004). However, the clinical usefulness of plasma triglyceride 
concentrations as an independent risk factor of ischemic stroke 
risk remains controversial (Tell et al., 1988; Ridker, 2008). Some 
claim that elevated triglyceride levels are strong independent fac-
tors increasing risk of ischemic stroke (Lindenstrom et al., 1994; 
Ahmed et al., 1999; Milionis et al., 2005) while others have found the 
relationship either to exist only in women (Bansal et al., 2007), men 
(Salonen et al., 1982), or not at all (Haheim et al., 1993; Bowman 
et al., 2003).
Some of the discrepancy in the literature could be due to genetic 
heterogeneity within study samples (Havasi et al., 2006). Indeed, 
lipid profiles can vary largely at the individual level, and are affected 
by factors like ethnicity, alcohol consumption, and menopausal 
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Study elIgIbIlIty
The review included any human prospective cohort, case– control, 
and nested case–control study having to do either directly or 
indirectly with ischemic stroke published or translated into the 
English language. Because this review focuses exclusively on 
ischemic stroke risk, studies were only eligible for inclusion if a 
computed tomography scan or magnetic resonance imaging had 
been performed on patients to distinguish between ischemic and 
hemorrhagic strokes.
IncluSIon crIterIa
Case–control and prospective cohort studies were included if 
they had at least 100 participants per group and a statistical 
analysis had been conducted measuring the relationship between 
triglyceride levels and stroke endpoint (fatal and/or non-fatal 
ischemic stroke and transient ischemic attack). Additionally, we 
excluded all studies that did not include a specific ischemic stroke 
patient subset within their study, thereby excluding studies that 
focused exclusively on other forms of stroke (e.g., subarach-
noid hemorrhage). This was performed in an effort to  minimize 
The purpose of this review is to summarize and synthesize 
results from pertinent studies in an effort to determine if fasting 
and/or non-fasting triglycerides are a risk factor for ischemic stroke. 
We hypothesized that elevated non-fasting plasma triglyceride con-
centrations are indicative of stroke risk.
MaterIalS and MethodS
SearchIng data SourceS
This review was conducted in accordance with MOOSE guide-
lines (Stroup et al., 2000). We identified original epidemiological 
studies assessing the relationship between stroke risk and fasting 
or non-fasting triglyceride concentrations using two independ-
ent computerized literature searches (Figure 1). The PubMed and 
ScienceDirect databases were searched by Christopher Leonards 
and Jana Batluk between April 14th and 27th April, 2010, using 
the medical subject heading (MESH) terms “triglycerides” and 
“stroke.” Hand searching was also performed of all included stud-
ies and relevant review articles. Unpublished studies were identi-
fied by searching the book of abstracts from the European Stroke 
Conferences ranging from the years 2006 through 2008.
Case-control Studies 
Stroke & Triglyceride Literature 
Prospecve Cohort Studies 
Fasng 
Triglyceride 
Measurement 
Non-fasng 
Triglyceride 
Measurement 
Fasng 
Triglyceride 
Measurement 
Non-fasng 
Triglyceride 
Measurement 
Triglyceride 
Values in Men vs. 
Women 
Triglyceride 
Values in Men vs. 
Women 
Triglyceride 
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Triglyceride 
Values in Men vs. 
Women 
FiguRe 1 | Flow diagram illustrating the subdivisions of the stroke literature pertaining to triglyceride levels.
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For some case–control studies no logistic regression was 
performed and no odds ratios are reported. If only mean trig-
lyceride values and SD’s were given for cases and controls, we 
decided not to convert the corresponding standardized differ-
ences to odds ratios and thereafter include these studies in our 
meta-analysis. First, this would not yield adjusted odds ratios 
and, second, the corresponding model assumptions which 
justify such procedures (e.g., Hasselblad and Hedges, 1995; 
Whitehead, 2002) are very specialized and in practice diffi-
cult to test. Thus, we only included case–control studies that 
reported odds ratios.
reSultS
Of 6896 citations identified by the computerized literature search 
in ScienceDirect and 1065 in PubMed, 35 epidemiological human 
studies examining the relationship between triglyceride concen-
trations and stroke risk that were identified by review of the title, 
abstract, and hand searching of references (Figure 3). Of these 35 
identified, 25 reports matched the inclusion criteria and are pre-
sented according to study design in Table 1 (prospective cohort) and 
Table 2 (case–control). The grounds for paper dismissal were lack 
of a specific ischemic stroke group (n = 6) (Rhoads and Feinleib, 
1983; Haheim et al., 1993; Njolstad et al., 1996; Wannamethee et al., 
2000; Shearman et al., 2005; Tokuda and Stein, 2005), duplicated 
data sets (n = 2) (Lindenstrom et al., 1994; Nordestgaard et al., 
2007), and two full text papers could not be accessed (Lapidus 
et al., 1985).
ProSPectIve cohort StudIeS
Thirteen prospective cohort studies (Table 1) were identified 
with a total of 99479 participants, and 4675 ischemic strokes that 
occurred during a mean follow-up period of 9.6 years. Samples 
varied regarding demographics and baseline characteristics. Nine 
of the prospective cohort studies measured triglyceride concentra-
tions in the fasting state (Salonen et al., 1982; Aronow et al., 1988; 
Simons et al., 1998; Psaty et al., 2001; Tanne et al., 2001; Shahar et al., 
2003; Onat et al., 2006; Nakamura et al., 2009), three non-fasting 
(Gordon et al., 1981; Iso et al., 2007; Freiberg et al., 2008), and 
one examined fasting versus non-fasting concentrations (Bansal 
et al., 2007). Fasting times across studies were variable, and ranged 
from 4 to 12 h.
non-faStIng ProSPectIve cohort StudIeS
Of the four studies that examined non-fasting triglyceride con-
centrations, three found that elevated triglyceride concentrations 
were independent risk factors for ischemic stroke in a sample 
including 1785 ischemic events after follow-up (Iso et al., 2007; 
Freiberg et al., 2008). One study found that triglyceride concen-
trations were not related to ischemic stroke risk in a sample of 
150 ischemic stroke patients (Gordon et al., 1981). Of the three 
positive studies, one was conducted in women only and exam-
ined the risk of ischemic stroke across a fasting (minimum 8-h 
fast) and non-fasting group and found that in a sample includ-
ing 265 ischemic events only non-fasting triglyceride concen-
trations were indicative of ischemic stroke risk (HR per 1-SD 
increase in triglyceride levels 1.98, 95% CI 1.21–3.25) (Bansal 
et al., 2007).
 potential confounds, as triglyceride levels have been more strongly 
 connected with ischemic than hemorrhagic stroke risk (Austin 
et al., 2000; Sarti and Gallagher, 2006). When more than one 
publication using the same sample was found, the publication 
with the most recent, complete data set was included. Results 
from meta-analyses are discussed herein, but were excluded from 
our analyses.
data extractIon
The data extracted from eligible reports are exhibited in Figure 2. 
Data were extracted by one author (Christopher Leonards) and 
reviewed independently (Martin Ebinger) to assure accuracy. 
Authors were not contacted for additional or unpublished data. 
Studies were then categorized based on study design and the direc-
tion of association found (Tables 1 and 2).
Meta-analySIS
We performed a meta-analysis of case–control studies that assessed 
plasma triglycerides and the risk of ischemic stroke using the MIX 
software package (Bax et al., 2006). Heterogeneity was assessed 
using the Q and I2 statistics and we calculated a pooled odds ratio 
within a fixed effect meta-analysis. Because stroke endpoint, fasting 
status, and statistical methods varied across studies, not all case–
control studies were included.
Report Characteristics
Study & First author’s names
Journal & Year of publication
Population Studied
Study Design
Selection of patients/Inclusion criteria
Baseline Characteristics
Overall sample size
Ischemic stroke sample size
Age
Gender
Lipid-profile levels for overall sample & ischemic stroke patients
Method
Blood sample collection
Fasting vs. nonfasting lipid profile measurements
Time spent fasting
Definition & identification of ischemic stroke (e.g. MRI)
Statistical methods
Outcome
Direction of association
Strength of association
Primary study outcome
FiguRe 2 | Panel illustrating data extracted from eligible reports.
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6896 citations identified 
by computerized search of 
ScienceDirect
1065 citations identified 
by computerized search 
of PubMed
Titles & abstracts were screened for original studies having to do with
triglycerides & stroke
79 full texts retrieved 
for further evaluation
61 full texts retrieved 
for further evaluation
35 reports fulfilled 
preliminary inclusion 
criteria
28 papers fulfilled 
preliminary inclusion 
criteria
Duplicate papers and studies reporting results using identical sample 
groups were excluded
25 reports included
FiguRe 3 | Flow diagram outlining the study inclusion process. MESH terms: “triglycerides” plus “stroke”.
faStIng ProSPectIve cohort StudIeS
Seven of the nine prospective cohort studies that measured trig-
lycerides in the fasting state identified elevated plasma triglyceride 
concentrations as an independent risk factor for ischemic stroke with 
1624 combined ischemic events (Salonen et al., 1982; Simons et al., 
1998; Psaty et al., 2001; Tanne et al., 2001; Onat et al., 2006; Nakamura 
et al., 2009). Two studies, with 1013 combined ischemic events, found 
no association to exist between ischemic stroke risk and elevated 
triglyceride levels (Aronow et al., 1988; Shahar et al., 2003).
caSe–control StudIeS
Twelve case–control studies were identified (Table 2) including 
3841 cases and 4715 controls. Three studies were nested within 
randomized clinical trials (Ahmed et al., 1999; Bowman et al., 2003; 
Patel et al., 2005), and baseline characteristics varied as did sample 
populations. One study (Bowman et al., 2003) measured triglycer-
ides in the non-fasting status.
Another study (Patel et al., 2005) measured both fasting and 
non-fasting plasma triglyceride concentrations. All other studies 
measured triglycerides in the fasting state only. Length of fasting 
varied between 4 and 12 h and was often not reported (n = 5).
non-faStIng caSe–control StudIeS
Two studies reported on triglyceride levels in the non-fasting state 
(Bowman et al., 2003; Patel et al., 2005). Both found no relation-
ship between ischemic stroke risk and elevated plasma triglycer-
ide concentrations (1191 cases). Interestingly however, though 
one study (Patel et al., 2005) reported no significant relationship 
to exist, Bowman et al. (2003) reported a significant difference 
between mean baseline non-fasting triglyceride concentrations in 
cases and controls, reporting a mean control group triglyceride 
concentration of 1.77 ± 1.05 mmol/L and mean case concentration 
of 2.17 ± 1.76 mmol/L (p < 0.01).
faStIng caSe–control StudIeS
Ten of the 12 case–control studies measured triglycerides in the 
fasting state (Table 2), two of which, assessed triglyceride concen-
trations in the acute stroke state (≤48-h post ictus) (Woo et al., 
1991; Shimo-Nakanishi et al., 2001). Of these 10 fasting state 
studies, five (838 ischemic cases) reported a positive association 
between increased plasma triglyceride levels and ischemic stroke 
risk (Ahmed et al., 1999; Chen et al., 2003; Laloux et al., 2004; 
Milionis et al., 2005; Saidi et al., 2007), and four (883 ischemic 
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odds ratios. There was, however, an uncertainty in I 2 correspond-
ing to a broad 95% CI. The pooled odds ratio within a fixed effect 
model (1.15, 95% CI, 1.08–1.21) and the estimated mean odds ratio 
within a random effects model (1.13, 95% CI, 1.02–1.25) were very 
close. Removing the only study (Bowman et al., 2003) with non-
fasting TG values in a sensitivity analysis did not change the result. 
However, when another study was excluded (Milionis et al., 2005) 
sensitivity analysis revealed loss of significance (for study inclusion 
criteria, see section Materials and methods).
dIScuSSIon
This review revealed that a vast array of conflicting results exist 
in the literature with regard to the impact that triglycerides have 
on ischemic stroke risk (Tables 1 and 2). Out of 12 case–control 
studies only seven studies that reported odds ratios were included 
in our meta-analysis. It revealed a significant odds ratio of 1.15 
(95% CI, 1.08–1.21) but the significance was attributable to a 
single study (Milionis et al., 2005) only. A sensitivity analysis 
revealed that this study contributed with a high weight to our 
meta-analysis and therefore strongly influenced our findings. In 
fact, significance was lost after the removal of this study [pooled 
odds ratio with 95% CI within a fixed effect model: 1.03 (0.85, 
1.25), estimate for the mean odds ratio with 95% CI for a random 
effects model: 1.03 (0.85, 1.26)]. Our literature search showed 
that very few (n = 3) original studies have specifically compared 
fasting with non-fasting triglyceride levels in relation to ischemic 
stroke risk (Patel et al., 2005; Bansal et al., 2007; Nordestgaard 
et al., 2007). Moreover, we observed that neither the time elapsed 
since the most recent meal, nor the content of that meal have 
been standardized.
Thus, to quell the debate between fasting versus non-fasting 
triglycerides, it might be beneficial to develop a standardized para-
digm for measuring triglycerides. An oral triglyceride tolerance 
test (oTTT) has recently been suggested as a possible approach 
(Mohanlal and Holman, 2004; Bansal et al., 2007; Ridker, 2008; 
Ebinger et al., 2010).
Our review and meta-analysis have a few limitations. First, only 
those studies published in the English language were included. 
Secondly, though we specified our inclusion and exclusion criteria 
no further method quality appraisal was performed. Third, various 
final endpoints were included in this review (ischemic stroke was 
the only endpoint used in our meta-analysis). Fourth, we did not 
differentiate between studies on first versus recurrent stroke.
One advantage of our meta-analysis is that we examined only 
ischemic stroke. As stroke is a heterogeneous condition, it is possible 
that plasma triglyceride concentrations correlate differently to vari-
ous subtypes. Studies performed by Bonaventure et al. (2009) and 
Psaty et al. (2004) have found an inverse relationship between trig-
lyceride concentrations and hemorrhagic stroke. This distinction 
between ischemic and hemorrhagic stroke could be of importance, 
as studies that combine all forms of stroke may be negating pos-
sible significant associations. Future work might include examin-
ing triglycerides as a risk factor for all stroke subtypes and across 
the various subtypes of ischemic stroke. We did not differentiate 
between the embolic, thrombotic, or lacunar subtypes of ischemic 
stroke as we found very little published information on the topic 
(Laloux et al., 2004).
cases) found no relationship to exist (Woo et al., 1991; Sacco et al., 
2001; Shimo-Nakanishi et al., 2001; Patel et al., 2005). One study 
combining ischemic and hemorrhagic cases found no relationship 
between fasting triglyceride levels and stroke (Woo et al., 1991).
gender dIfferenceS
A number of studies have directly investigated the relationship 
between triglycerides and stroke in both men and women with 
varying results. In a study conducted by Njolstad et al. (1996), 
elevated fasting plasma triglycerides were significant risk factors for 
ischemic stroke in women. A women’s study conducted by Bansal 
et al. (2007) showed similar findings measuring non-fasting triglyc-
erides. Of five men’s studies, three found no relationship between 
ischemic stroke and non-fasting triglycerides to exist (Rhoads and 
Feinleib, 1983; Haheim et al., 1993; Wannamethee et al., 2000) and 
two identified a positive relationship (Salonen et al., 1982; Iso et al., 
2007). Taking both genders into account, several studies have found 
both fasting and non-fasting triglycerides to be an independent 
risk factor for ischemic stroke (Ahmed et al., 1999; Iso et al., 2007; 
Freiberg et al., 2008).
Meta-analySIS
Seven case–control studies (Woo et al., 1991; Bowman et al., 
2003; Milionis et al., 2005; Patel et al., 2005; Amarenco et al., 
2006; Lipska et al., 2007; Saidi et al., 2007) were included in the 
meta-analysis, with a total of 5263 participants (for odds ratios, 
see Figure 4).
Based on the Q-statistic, the null-hypothesis that all seven stud-
ies share a common odds ratio could not be rejected (Q = 6.57, 
p = 0.36). There was no significant excess variation. The very low 
value for I2 (I2 = 8.76%) indicated that only a very small proportion 
of the observed variance reflected real differences between the seven 
FiguRe 4 | Forrest plot illustrating the odds ratios (95% Ci) of studies 
included in the meta-analysis.
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studies examining the possible benefit of non-fasting triglyceride 
 measurement, ideally differentiating between stroke subtypes, may 
be especially warranted.
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